

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.96235480 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.69253855 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.69253855 |
| 4 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.68958243 |
| 5 | positive thymic T cell selection (GO:0045059) | 5.46171219 |
| 6 | regulation of gamma-delta T cell activation (GO:0046643) | 5.44733747 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.24449007 |
| 8 | positive T cell selection (GO:0043368) | 4.83651391 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.69879175 |
| 10 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.60540094 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.58750849 |
| 12 | negative T cell selection (GO:0043383) | 4.36615299 |
| 13 | thymic T cell selection (GO:0045061) | 4.34485706 |
| 14 | negative thymic T cell selection (GO:0045060) | 4.21057458 |
| 15 | immunoglobulin mediated immune response (GO:0016064) | 4.19729136 |
| 16 | T cell selection (GO:0045058) | 4.17507334 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.16983016 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 4.16983016 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.16983016 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.16983016 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.16983016 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 4.16983016 |
| 23 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 4.06191369 |
| 24 | positive regulation of B cell differentiation (GO:0045579) | 4.03121614 |
| 25 | detection of bacterium (GO:0016045) | 4.01969237 |
| 26 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.00316040 |
| 27 | negative regulation of RNA splicing (GO:0033119) | 3.93639623 |
| 28 | detection of other organism (GO:0098543) | 3.79864849 |
| 29 | positive regulation of histone deacetylation (GO:0031065) | 3.79036400 |
| 30 | megakaryocyte development (GO:0035855) | 3.74071463 |
| 31 | B cell receptor signaling pathway (GO:0050853) | 3.71878358 |
| 32 | response to muramyl dipeptide (GO:0032495) | 3.68656305 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.66925890 |
| 34 | ribosomal small subunit assembly (GO:0000028) | 3.62133055 |
| 35 | negative regulation of cell killing (GO:0031342) | 3.60843696 |
| 36 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.60843696 |
| 37 | neutrophil activation involved in immune response (GO:0002283) | 3.60143434 |
| 38 | interferon-gamma production (GO:0032609) | 3.57280892 |
| 39 | regulation of B cell differentiation (GO:0045577) | 3.55793111 |
| 40 | negative regulation of phagocytosis (GO:0050765) | 3.55188483 |
| 41 | nucleosome disassembly (GO:0006337) | 3.47762979 |
| 42 | protein-DNA complex disassembly (GO:0032986) | 3.47762979 |
| 43 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.45878265 |
| 44 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.40362686 |
| 45 | natural killer cell differentiation (GO:0001779) | 3.39716911 |
| 46 | B cell mediated immunity (GO:0019724) | 3.37827384 |
| 47 | response to interleukin-15 (GO:0070672) | 3.37127042 |
| 48 | negative regulation of innate immune response (GO:0045824) | 3.29972869 |
| 49 | T cell receptor signaling pathway (GO:0050852) | 3.28926016 |
| 50 | T cell homeostasis (GO:0043029) | 3.28300516 |
| 51 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.28048163 |
| 52 | regulation of erythrocyte differentiation (GO:0045646) | 3.27593187 |
| 53 | leukocyte aggregation (GO:0070486) | 3.27069255 |
| 54 | regulation of mast cell degranulation (GO:0043304) | 3.27045608 |
| 55 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.24920700 |
| 56 | response to host immune response (GO:0052572) | 3.24920700 |
| 57 | response to peptidoglycan (GO:0032494) | 3.24241646 |
| 58 | negative regulation of mRNA processing (GO:0050686) | 3.22912586 |
| 59 | T cell migration (GO:0072678) | 3.21994738 |
| 60 | NIK/NF-kappaB signaling (GO:0038061) | 3.21439844 |
| 61 | neutrophil activation (GO:0042119) | 3.15669587 |
| 62 | viral transcription (GO:0019083) | 3.15409009 |
| 63 | cellular response to zinc ion (GO:0071294) | 3.13289785 |
| 64 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.10611006 |
| 65 | tolerance induction (GO:0002507) | 3.09344095 |
| 66 | positive regulation of gene expression, epigenetic (GO:0045815) | 3.06948302 |
| 67 | lymphocyte homeostasis (GO:0002260) | 3.06752996 |
| 68 | positive regulation of protein deacetylation (GO:0090312) | 3.06076847 |
| 69 | modulation by virus of host process (GO:0019054) | 3.02333570 |
| 70 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.02086766 |
| 71 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.00569543 |
| 72 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.99244001 |
| 73 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.97872352 |
| 74 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.96342070 |
| 75 | Peyers patch development (GO:0048541) | 2.96342070 |
| 76 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.95471395 |
| 77 | response to host (GO:0075136) | 2.95471395 |
| 78 | response to host defenses (GO:0052200) | 2.95471395 |
| 79 | negative regulation of mRNA metabolic process (GO:1903312) | 2.92446889 |
| 80 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.92014479 |
| 81 | granulocyte activation (GO:0036230) | 2.91939576 |
| 82 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.90579501 |
| 83 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 2.88540745 |
| 84 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.88196210 |
| 85 | embryonic hemopoiesis (GO:0035162) | 2.88195040 |
| 86 | T cell costimulation (GO:0031295) | 2.88054318 |
| 87 | regulation of leukocyte degranulation (GO:0043300) | 2.88042645 |
| 88 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.86703753 |
| 89 | dosage compensation (GO:0007549) | 2.85699904 |
| 90 | positive regulation of antigen processing and presentation (GO:0002579) | 2.85641245 |
| 91 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.84726148 |
| 92 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.84410208 |
| 93 | response to interferon-beta (GO:0035456) | 2.83027212 |
| 94 | translational termination (GO:0006415) | 2.82376475 |
| 95 | respiratory burst (GO:0045730) | 2.81782550 |
| 96 | cellular response to virus (GO:0098586) | 2.81748911 |
| 97 | lymphocyte costimulation (GO:0031294) | 2.81512535 |
| 98 | DNA unwinding involved in DNA replication (GO:0006268) | 2.81022337 |
| 99 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.79308856 |
| 100 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.78420523 |
| 101 | negative regulation of granulocyte differentiation (GO:0030853) | 2.78143896 |
| 102 | regulation of antigen processing and presentation (GO:0002577) | 2.77329380 |
| 103 | hepatocyte apoptotic process (GO:0097284) | 2.77301425 |
| 104 | negative regulation of T cell mediated immunity (GO:0002710) | 2.76194973 |
| 105 | macrophage activation involved in immune response (GO:0002281) | 2.74568058 |
| 106 | positive regulation of granulocyte differentiation (GO:0030854) | 2.74216697 |
| 107 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.73759536 |
| 108 | negative regulation of B cell apoptotic process (GO:0002903) | 2.73250118 |
| 109 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.72750371 |
| 110 | leukocyte homeostasis (GO:0001776) | 2.72444337 |
| 111 | regulation of granulocyte differentiation (GO:0030852) | 2.71980889 |
| 112 | actin nucleation (GO:0045010) | 2.71257730 |
| 113 | translational elongation (GO:0006414) | 2.70511684 |
| 114 | regulation of T cell tolerance induction (GO:0002664) | 2.69639411 |
| 115 | erythrocyte maturation (GO:0043249) | 2.67777834 |
| 116 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.67508925 |
| 117 | mast cell activation (GO:0045576) | 2.66382586 |
| 118 | myeloid cell activation involved in immune response (GO:0002275) | 2.65541842 |
| 119 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.64804686 |
| 120 | regulation of protein heterodimerization activity (GO:0043497) | 2.64743539 |
| 121 | response to type I interferon (GO:0034340) | 2.63488039 |
| 122 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.62243207 |
| 123 | leukocyte degranulation (GO:0043299) | 2.61106679 |
| 124 | detection of external biotic stimulus (GO:0098581) | 2.60395252 |
| 125 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.60076737 |
| 126 | germinal center formation (GO:0002467) | 2.59998930 |
| 127 | cellular response to interleukin-15 (GO:0071350) | 2.59562831 |
| 128 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.58814033 |
| 129 | negative regulation of interleukin-12 production (GO:0032695) | 2.58527112 |
| 130 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.58198375 |
| 131 | cellular response to interleukin-4 (GO:0071353) | 2.58156752 |
| 132 | platelet formation (GO:0030220) | 2.54044458 |
| 133 | positive regulation of RNA splicing (GO:0033120) | 2.53892490 |
| 134 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.53734061 |
| 135 | regulation of mast cell activation (GO:0033003) | 2.53704677 |
| 136 | histone H2A acetylation (GO:0043968) | 2.53374017 |
| 137 | natural killer cell activation (GO:0030101) | 2.53129169 |
| 138 | definitive hemopoiesis (GO:0060216) | 2.51862289 |
| 139 | pre-miRNA processing (GO:0031054) | 2.51189395 |
| 140 | type I interferon signaling pathway (GO:0060337) | 2.51149303 |
| 141 | cellular response to type I interferon (GO:0071357) | 2.51149303 |
| 142 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.49505813 |
| 143 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.48280428 |
| 144 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.47994389 |
| 145 | negative regulation of histone methylation (GO:0031061) | 2.47049368 |
| 146 | response to pheromone (GO:0019236) | 2.45657939 |
| 147 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.44656351 |
| 148 | regulation of defense response to virus by virus (GO:0050690) | 2.43108407 |
| 149 | angiogenesis involved in wound healing (GO:0060055) | 2.42647827 |
| 150 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.42158324 |
| 151 | positive regulation by host of viral transcription (GO:0043923) | 2.41691080 |
| 152 | adaptation of signaling pathway (GO:0023058) | 2.40754869 |
| 153 | mRNA stabilization (GO:0048255) | 2.40130241 |
| 154 | RNA stabilization (GO:0043489) | 2.40130241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.46808333 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 4.38329500 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.51750274 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.38533576 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.16087230 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.05292068 |
| 7 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.69532915 |
| 8 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 2.68163989 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.66249253 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.63929370 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.62532738 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.57004823 |
| 13 | UTX_26944678_Chip-Seq_JUKART_Human | 2.55860208 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.51896771 |
| 15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.37446289 |
| 16 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.36061595 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.33287383 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.32293736 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25994658 |
| 20 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.24970692 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.24527375 |
| 22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.19144483 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.12786970 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.12639413 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.10585199 |
| 26 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.09963684 |
| 27 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07332024 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.04611910 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.03306245 |
| 30 | * MYB_26560356_Chip-Seq_TH2_Human | 2.00522369 |
| 31 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97042407 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.95498086 |
| 33 | * MYB_26560356_Chip-Seq_TH1_Human | 1.91167653 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.89394662 |
| 35 | MAF_26560356_Chip-Seq_TH2_Human | 1.85004319 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.81348530 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80388611 |
| 38 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.80051525 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.79832404 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.77047769 |
| 41 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.76857111 |
| 42 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.74569906 |
| 43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.67568909 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63770031 |
| 45 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.61769755 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61629518 |
| 47 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.61581486 |
| 48 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.60295198 |
| 49 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58430434 |
| 50 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.55778113 |
| 51 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.55271165 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54488404 |
| 53 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.53618896 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.53216246 |
| 55 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.49213864 |
| 56 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.42082244 |
| 57 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.41284236 |
| 58 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36953279 |
| 59 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.36639295 |
| 60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33654197 |
| 61 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.33091133 |
| 62 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32858691 |
| 63 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32849489 |
| 64 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.32685423 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32590690 |
| 66 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.30020234 |
| 67 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.28711268 |
| 68 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.28574214 |
| 69 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27990074 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26992513 |
| 71 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.26387567 |
| 72 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.25925991 |
| 73 | P68_20966046_ChIP-Seq_HELA_Human | 1.25465347 |
| 74 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.25214501 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24668598 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24637387 |
| 77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24223573 |
| 78 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.23372585 |
| 79 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23099751 |
| 80 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21226674 |
| 81 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.20086239 |
| 82 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.19340028 |
| 83 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18592963 |
| 84 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.15855174 |
| 85 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.15791608 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14614916 |
| 87 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.14606221 |
| 88 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12689097 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12297681 |
| 90 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.11750320 |
| 91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11499687 |
| 92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10654401 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09863358 |
| 94 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08870967 |
| 95 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.08555941 |
| 96 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.07899871 |
| 97 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.07860903 |
| 98 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07794898 |
| 99 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.07656251 |
| 100 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07639160 |
| 101 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.05448367 |
| 102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05323176 |
| 103 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04861282 |
| 104 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03566943 |
| 105 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02629333 |
| 106 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.01922195 |
| 107 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01047252 |
| 108 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.01010199 |
| 109 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.00826565 |
| 110 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99847217 |
| 111 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.99821708 |
| 112 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.99223174 |
| 113 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.98050594 |
| 114 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97541516 |
| 115 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.96272921 |
| 116 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95312908 |
| 117 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94643009 |
| 118 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.94474002 |
| 119 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93785584 |
| 120 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92866404 |
| 121 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.86811321 |
| 122 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.86606408 |
| 123 | GATA1_22025678_ChIP-Seq_K562_Human | 0.86176358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.80187682 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.22826865 |
| 3 | MP0003300_gastrointestinal_ulcer | 3.19845185 |
| 4 | MP0000685_abnormal_immune_system | 3.12185112 |
| 5 | MP0005671_abnormal_response_to | 2.72025198 |
| 6 | MP0002398_abnormal_bone_marrow | 2.68081978 |
| 7 | MP0005387_immune_system_phenotype | 2.66993877 |
| 8 | MP0001790_abnormal_immune_system | 2.66993877 |
| 9 | MP0001800_abnormal_humoral_immune | 2.66415072 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.63738349 |
| 11 | MP0009278_abnormal_bone_marrow | 2.62238303 |
| 12 | MP0000703_abnormal_thymus_morphology | 2.47963212 |
| 13 | MP0008260_abnormal_autophagy | 2.45296321 |
| 14 | MP0003303_peritoneal_inflammation | 2.31433147 |
| 15 | MP0005174_abnormal_tail_pigmentation | 2.30968868 |
| 16 | MP0000465_gastrointestinal_hemorrhage | 2.27047518 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.23744318 |
| 18 | MP0004808_abnormal_hematopoietic_stem | 2.20055314 |
| 19 | MP0001819_abnormal_immune_cell | 2.19797789 |
| 20 | MP0005058_abnormal_lysosome_morphology | 2.18344363 |
| 21 | MP0002722_abnormal_immune_system | 2.18222455 |
| 22 | MP0000716_abnormal_immune_system | 2.14584592 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.12316119 |
| 24 | MP0003866_abnormal_defecation | 2.10996471 |
| 25 | MP0005397_hematopoietic_system_phenotyp | 2.10168626 |
| 26 | MP0001545_abnormal_hematopoietic_system | 2.10168626 |
| 27 | MP0000689_abnormal_spleen_morphology | 2.09742462 |
| 28 | MP0002723_abnormal_immune_serum | 2.06896818 |
| 29 | MP0002166_altered_tumor_susceptibility | 2.05315289 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.99631431 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.99002546 |
| 32 | MP0001873_stomach_inflammation | 1.97263901 |
| 33 | MP0008961_abnormal_basal_metabolism | 1.95389271 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.93435976 |
| 35 | MP0002405_respiratory_system_inflammati | 1.91607645 |
| 36 | MP0002429_abnormal_blood_cell | 1.90441085 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.86426005 |
| 38 | MP0005025_abnormal_response_to | 1.77610906 |
| 39 | MP0003436_decreased_susceptibility_to | 1.75412327 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.73889938 |
| 41 | MP0002877_abnormal_melanocyte_morpholog | 1.71778173 |
| 42 | MP0000490_abnormal_crypts_of | 1.68528917 |
| 43 | MP0006054_spinal_hemorrhage | 1.58422158 |
| 44 | MP0002653_abnormal_ependyma_morphology | 1.51449934 |
| 45 | MP0003111_abnormal_nucleus_morphology | 1.48091438 |
| 46 | MP0004947_skin_inflammation | 1.47921887 |
| 47 | MP0005451_abnormal_body_composition | 1.44584076 |
| 48 | MP0005409_darkened_coat_color | 1.43389581 |
| 49 | MP0009785_altered_susceptibility_to | 1.38567903 |
| 50 | MP0008007_abnormal_cellular_replicative | 1.36317772 |
| 51 | MP0005076_abnormal_cell_differentiation | 1.33999527 |
| 52 | MP0004510_myositis | 1.30183095 |
| 53 | MP0002419_abnormal_innate_immunity | 1.27195732 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 1.26284932 |
| 55 | MP0006082_CNS_inflammation | 1.26002792 |
| 56 | MP0008469_abnormal_protein_level | 1.25890762 |
| 57 | MP0003077_abnormal_cell_cycle | 1.24599989 |
| 58 | MP0004381_abnormal_hair_follicle | 1.23661473 |
| 59 | MP0002095_abnormal_skin_pigmentation | 1.23566299 |
| 60 | MP0002006_tumorigenesis | 1.23044273 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.21166317 |
| 62 | MP0002019_abnormal_tumor_incidence | 1.19841767 |
| 63 | MP0000569_abnormal_digit_pigmentation | 1.19319583 |
| 64 | MP0003828_pulmonary_edema | 1.19206220 |
| 65 | MP0003075_altered_response_to | 1.19127539 |
| 66 | MP0000015_abnormal_ear_pigmentation | 1.18896154 |
| 67 | MP0002089_abnormal_postnatal_growth/wei | 1.17512957 |
| 68 | MP0005310_abnormal_salivary_gland | 1.17098467 |
| 69 | MP0002148_abnormal_hypersensitivity_rea | 1.14952879 |
| 70 | MP0000566_synostosis | 1.13352091 |
| 71 | MP0009840_abnormal_foam_cell | 1.10802123 |
| 72 | MP0000678_abnormal_parathyroid_gland | 1.08737109 |
| 73 | MP0009764_decreased_sensitivity_to | 1.05024465 |
| 74 | MP0002009_preneoplasia | 1.00518655 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 0.97772954 |
| 76 | MP0010094_abnormal_chromosome_stability | 0.96447613 |
| 77 | MP0008569_lethality_at_weaning | 0.94292341 |
| 78 | MP0005083_abnormal_biliary_tract | 0.94122850 |
| 79 | MP0001851_eye_inflammation | 0.93196294 |
| 80 | MP0004147_increased_porphyrin_level | 0.92158852 |
| 81 | MP0009763_increased_sensitivity_to | 0.90739793 |
| 82 | MP0002928_abnormal_bile_duct | 0.90270126 |
| 83 | MP0009379_abnormal_foot_pigmentation | 0.90258277 |
| 84 | MP0002132_abnormal_respiratory_system | 0.90217900 |
| 85 | MP0003693_abnormal_embryo_hatching | 0.89754836 |
| 86 | MP0002933_joint_inflammation | 0.89045264 |
| 87 | MP0006036_abnormal_mitochondrial_physio | 0.88760609 |
| 88 | MP0005390_skeleton_phenotype | 0.86941258 |
| 89 | MP0000313_abnormal_cell_death | 0.85667855 |
| 90 | MP0002998_abnormal_bone_remodeling | 0.84540413 |
| 91 | MP0008995_early_reproductive_senescence | 0.78950541 |
| 92 | MP0004185_abnormal_adipocyte_glucose | 0.78684142 |
| 93 | MP0008874_decreased_physiological_sensi | 0.78596412 |
| 94 | MP0001849_ear_inflammation | 0.77002478 |
| 95 | MP0002138_abnormal_hepatobiliary_system | 0.76645868 |
| 96 | MP0000477_abnormal_intestine_morphology | 0.76105658 |
| 97 | MP0010352_gastrointestinal_tract_polyps | 0.75765011 |
| 98 | MP0003943_abnormal_hepatobiliary_system | 0.74699637 |
| 99 | MP0002693_abnormal_pancreas_physiology | 0.74640967 |
| 100 | MP0000858_altered_metastatic_potential | 0.72252564 |
| 101 | MP0001944_abnormal_pancreas_morphology | 0.71728643 |
| 102 | MP0002332_abnormal_exercise_endurance | 0.71583691 |
| 103 | MP0008058_abnormal_DNA_repair | 0.71290441 |
| 104 | MP0003787_abnormal_imprinting | 0.70831057 |
| 105 | MP0005166_decreased_susceptibility_to | 0.70628247 |
| 106 | MP0000350_abnormal_cell_proliferation | 0.70262324 |
| 107 | MP0000343_altered_response_to | 0.68071630 |
| 108 | MP0003795_abnormal_bone_structure | 0.67925405 |
| 109 | MP0005670_abnormal_white_adipose | 0.67321683 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.67184581 |
| 111 | MP0003183_abnormal_peptide_metabolism | 0.66827777 |
| 112 | MP0001270_distended_abdomen | 0.66725558 |
| 113 | MP0003806_abnormal_nucleotide_metabolis | 0.66329503 |
| 114 | MP0003329_amyloid_beta_deposits | 0.65099904 |
| 115 | MP0001663_abnormal_digestive_system | 0.64363051 |
| 116 | MP0005666_abnormal_adipose_tissue | 0.63545926 |
| 117 | MP0003724_increased_susceptibility_to | 0.63469065 |
| 118 | MP0003191_abnormal_cellular_cholesterol | 0.62508498 |
| 119 | MP0001879_abnormal_lymphatic_vessel | 0.62199979 |
| 120 | MP0001533_abnormal_skeleton_physiology | 0.61585782 |
| 121 | MP0009672_abnormal_birth_weight | 0.61179615 |
| 122 | MP0005375_adipose_tissue_phenotype | 0.60767232 |
| 123 | MP0000604_amyloidosis | 0.59308701 |
| 124 | MP0005535_abnormal_body_temperature | 0.59026982 |
| 125 | MP0004957_abnormal_blastocyst_morpholog | 0.58473847 |
| 126 | MP0001853_heart_inflammation | 0.57434216 |
| 127 | MP0005220_abnormal_exocrine_pancreas | 0.57365945 |
| 128 | MP0008004_abnormal_stomach_pH | 0.56925744 |
| 129 | MP0001730_embryonic_growth_arrest | 0.56900685 |
| 130 | MP0000751_myopathy | 0.55530436 |
| 131 | MP0008873_increased_physiological_sensi | 0.54611029 |
| 132 | MP0005319_abnormal_enzyme/_coenzyme | 0.53790200 |
| 133 | MP0003221_abnormal_cardiomyocyte_apopto | 0.53742817 |
| 134 | MP0000681_abnormal_thyroid_gland | 0.52372619 |
| 135 | MP0002277_abnormal_respiratory_mucosa | 0.51308849 |
| 136 | MP0005621_abnormal_cell_physiology | 0.50638316 |
| 137 | MP0001986_abnormal_taste_sensitivity | 0.49773692 |
| 138 | MP0002083_premature_death | 0.49546463 |
| 139 | MP0003448_altered_tumor_morphology | 0.48286074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.91111480 |
| 2 | Abnormality of the fingertips (HP:0001211) | 4.51084069 |
| 3 | Panhypogammaglobulinemia (HP:0003139) | 4.44148375 |
| 4 | Stomatitis (HP:0010280) | 4.20856107 |
| 5 | Hyperacusis (HP:0010780) | 3.87609311 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.78321658 |
| 7 | IgM deficiency (HP:0002850) | 3.68414392 |
| 8 | Recurrent viral infections (HP:0004429) | 3.67091468 |
| 9 | Chronic otitis media (HP:0000389) | 3.66153199 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 3.64094250 |
| 11 | Obstructive lung disease (HP:0006536) | 3.64094250 |
| 12 | Agammaglobulinemia (HP:0004432) | 3.60141311 |
| 13 | Gastrointestinal inflammation (HP:0004386) | 3.50627166 |
| 14 | Inflammation of the large intestine (HP:0002037) | 3.46165193 |
| 15 | Cellulitis (HP:0100658) | 3.38575417 |
| 16 | Colitis (HP:0002583) | 3.36608286 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.34629599 |
| 18 | Recurrent bronchitis (HP:0002837) | 3.33866907 |
| 19 | Papilloma (HP:0012740) | 3.23457146 |
| 20 | Verrucae (HP:0200043) | 3.23457146 |
| 21 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.22324645 |
| 22 | Purpura (HP:0000979) | 3.17606972 |
| 23 | Increased IgM level (HP:0003496) | 3.16797928 |
| 24 | Abnormality of the nasal mucosa (HP:0000433) | 3.15836044 |
| 25 | Abnormality of T cells (HP:0002843) | 3.06771501 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.05014667 |
| 27 | T lymphocytopenia (HP:0005403) | 3.04452781 |
| 28 | Spontaneous hematomas (HP:0007420) | 3.01349335 |
| 29 | Increased cerebral lipofuscin (HP:0011813) | 2.98901195 |
| 30 | Nasal polyposis (HP:0100582) | 2.93687053 |
| 31 | Meningitis (HP:0001287) | 2.92849512 |
| 32 | Myositis (HP:0100614) | 2.92469359 |
| 33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.89374122 |
| 34 | Abnormality of T cell physiology (HP:0011840) | 2.83470556 |
| 35 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.81575921 |
| 36 | Recurrent cutaneous fungal infections (HP:0011370) | 2.81575921 |
| 37 | Abnormality of T cell number (HP:0011839) | 2.79243523 |
| 38 | Pustule (HP:0200039) | 2.76287864 |
| 39 | Loss of speech (HP:0002371) | 2.70878045 |
| 40 | Insomnia (HP:0100785) | 2.70865299 |
| 41 | Lymphopenia (HP:0001888) | 2.70725714 |
| 42 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.69688422 |
| 43 | Thrombocytosis (HP:0001894) | 2.67583679 |
| 44 | Urticaria (HP:0001025) | 2.64724043 |
| 45 | Growth hormone excess (HP:0000845) | 2.60382919 |
| 46 | Hypergammaglobulinemia (HP:0010702) | 2.58217267 |
| 47 | Polygenic inheritance (HP:0010982) | 2.52948322 |
| 48 | Eczematoid dermatitis (HP:0000976) | 2.52470974 |
| 49 | Peripheral hypomyelination (HP:0007182) | 2.51133297 |
| 50 | Dysostosis multiplex (HP:0000943) | 2.46879417 |
| 51 | B lymphocytopenia (HP:0010976) | 2.46044129 |
| 52 | Abnormality of B cell number (HP:0010975) | 2.46044129 |
| 53 | Gastrointestinal infarctions (HP:0005244) | 2.43232144 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.42413487 |
| 55 | Hepatosplenomegaly (HP:0001433) | 2.42239390 |
| 56 | Prolonged bleeding time (HP:0003010) | 2.40590987 |
| 57 | Increased IgE level (HP:0003212) | 2.40120992 |
| 58 | Sepsis (HP:0100806) | 2.39552344 |
| 59 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.36447686 |
| 60 | Interstitial pulmonary disease (HP:0006530) | 2.36210284 |
| 61 | Cholecystitis (HP:0001082) | 2.35425263 |
| 62 | Abnormal gallbladder physiology (HP:0012438) | 2.35425263 |
| 63 | Elfin facies (HP:0004428) | 2.34012179 |
| 64 | Abnormality of glycolipid metabolism (HP:0010969) | 2.31751742 |
| 65 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.31751742 |
| 66 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.31751742 |
| 67 | Thyroiditis (HP:0100646) | 2.31518623 |
| 68 | Gingival bleeding (HP:0000225) | 2.31093965 |
| 69 | Acute lymphatic leukemia (HP:0006721) | 2.28997843 |
| 70 | Gastrointestinal stroma tumor (HP:0100723) | 2.27254996 |
| 71 | Severe combined immunodeficiency (HP:0004430) | 2.27024280 |
| 72 | Progressive neurologic deterioration (HP:0002344) | 2.24385237 |
| 73 | Long eyelashes (HP:0000527) | 2.24282210 |
| 74 | Episodic fever (HP:0001954) | 2.23839153 |
| 75 | Visual hallucinations (HP:0002367) | 2.23826713 |
| 76 | Chest pain (HP:0100749) | 2.23271748 |
| 77 | Recurrent abscess formation (HP:0002722) | 2.22483914 |
| 78 | Periodontitis (HP:0000704) | 2.20176737 |
| 79 | Pulmonary infiltrates (HP:0002113) | 2.19928560 |
| 80 | Stomach cancer (HP:0012126) | 2.18618800 |
| 81 | Long palpebral fissure (HP:0000637) | 2.17378106 |
| 82 | Petechiae (HP:0000967) | 2.17345047 |
| 83 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.16819234 |
| 84 | Short 4th metacarpal (HP:0010044) | 2.16819234 |
| 85 | Ragged-red muscle fibers (HP:0003200) | 2.16757201 |
| 86 | Combined immunodeficiency (HP:0005387) | 2.15970375 |
| 87 | Hypochromic microcytic anemia (HP:0004840) | 2.15288631 |
| 88 | Hypertensive crisis (HP:0100735) | 2.15157841 |
| 89 | Autoimmune hemolytic anemia (HP:0001890) | 2.12601553 |
| 90 | Keratoconjunctivitis sicca (HP:0001097) | 2.09049425 |
| 91 | Viral hepatitis (HP:0006562) | 2.07905239 |
| 92 | Overriding aorta (HP:0002623) | 2.07867124 |
| 93 | Basal cell carcinoma (HP:0002671) | 2.06381256 |
| 94 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.05624922 |
| 95 | Increased serum ferritin (HP:0003281) | 2.05619190 |
| 96 | IgG deficiency (HP:0004315) | 2.04805796 |
| 97 | Ankle clonus (HP:0011448) | 2.04191447 |
| 98 | Gingivitis (HP:0000230) | 2.02635243 |
| 99 | Bronchitis (HP:0012387) | 2.00668180 |
| 100 | Abnormality of iron homeostasis (HP:0011031) | 1.99592402 |
| 101 | Increased nuchal translucency (HP:0010880) | 1.99344067 |
| 102 | Hematochezia (HP:0002573) | 1.99120146 |
| 103 | Abnormality of the prostate (HP:0008775) | 1.98937735 |
| 104 | Hypochromic anemia (HP:0001931) | 1.98331646 |
| 105 | Fatigue (HP:0012378) | 1.98299945 |
| 106 | Volvulus (HP:0002580) | 1.97432168 |
| 107 | Acute hepatic failure (HP:0006554) | 1.96645080 |
| 108 | Renovascular hypertension (HP:0100817) | 1.95961763 |
| 109 | Bicuspid aortic valve (HP:0001647) | 1.94307486 |
| 110 | Hemoptysis (HP:0002105) | 1.94126174 |
| 111 | Myopathic facies (HP:0002058) | 1.93953245 |
| 112 | Pointed chin (HP:0000307) | 1.92921744 |
| 113 | Slow saccadic eye movements (HP:0000514) | 1.92816414 |
| 114 | Autoimmune thrombocytopenia (HP:0001973) | 1.92458474 |
| 115 | Orchitis (HP:0100796) | 1.92092110 |
| 116 | Abnormality of the pleura (HP:0002103) | 1.91929430 |
| 117 | Eosinophilia (HP:0001880) | 1.91571556 |
| 118 | Reticulocytopenia (HP:0001896) | 1.91326707 |
| 119 | Osteomyelitis (HP:0002754) | 1.90800445 |
| 120 | Chronic sinusitis (HP:0011109) | 1.90557561 |
| 121 | Keratoconjunctivitis (HP:0001096) | 1.89305608 |
| 122 | Encephalitis (HP:0002383) | 1.89038810 |
| 123 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.88804739 |
| 124 | Joint swelling (HP:0001386) | 1.88399557 |
| 125 | Seborrheic dermatitis (HP:0001051) | 1.88018057 |
| 126 | Recurrent sinusitis (HP:0011108) | 1.87859933 |
| 127 | Thin bony cortex (HP:0002753) | 1.86410782 |
| 128 | Recurrent skin infections (HP:0001581) | 1.85573277 |
| 129 | Epistaxis (HP:0000421) | 1.85393478 |
| 130 | Increased density of long bones (HP:0006392) | 1.84580423 |
| 131 | Lymphoma (HP:0002665) | 1.84292661 |
| 132 | Obsessive-compulsive behavior (HP:0000722) | 1.83549277 |
| 133 | Cerebral aneurysm (HP:0004944) | 1.83230600 |
| 134 | Mediastinal lymphadenopathy (HP:0100721) | 1.82757189 |
| 135 | Recurrent bacterial skin infections (HP:0005406) | 1.82720016 |
| 136 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.82328875 |
| 137 | Leukocytosis (HP:0001974) | 1.79718108 |
| 138 | Emphysema (HP:0002097) | 1.78932598 |
| 139 | Microcytic anemia (HP:0001935) | 1.78729363 |
| 140 | Abnormality of the endocardium (HP:0004306) | 1.78649687 |
| 141 | Renal duplication (HP:0000075) | 1.77866319 |
| 142 | Arterial thrombosis (HP:0004420) | 1.76466041 |
| 143 | Prominent nose (HP:0000448) | 1.75810838 |
| 144 | Abnormality of eosinophils (HP:0001879) | 1.75265469 |
| 145 | Retrobulbar optic neuritis (HP:0100654) | 1.72980196 |
| 146 | Optic neuritis (HP:0100653) | 1.72980196 |
| 147 | Vasculitis (HP:0002633) | 1.72764613 |
| 148 | Granulocytopenia (HP:0001913) | 1.70923245 |
| 149 | Limb hypertonia (HP:0002509) | 1.69081399 |
| 150 | Deep palmar crease (HP:0006191) | 1.68407558 |
| 151 | Optic nerve coloboma (HP:0000588) | 1.67113829 |
| 152 | Flat cornea (HP:0007720) | 1.67083165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.54456428 |
| 2 | MAP3K10 | 3.88140993 |
| 3 | EEF2K | 3.62172570 |
| 4 | TRIB3 | 3.44242975 |
| 5 | PRPF4B | 3.00169709 |
| 6 | RIPK4 | 2.75525935 |
| 7 | PKN2 | 2.63395894 |
| 8 | SIK3 | 2.41566544 |
| 9 | ERN1 | 2.17443458 |
| 10 | BTK | 1.95307837 |
| 11 | ZAP70 | 1.92633468 |
| 12 | GRK6 | 1.82531407 |
| 13 | TESK1 | 1.76957795 |
| 14 | TXK | 1.72770772 |
| 15 | NEK2 | 1.72684019 |
| 16 | JAK3 | 1.72044114 |
| 17 | MAP4K2 | 1.70327590 |
| 18 | TAOK2 | 1.69872303 |
| 19 | STK10 | 1.67926682 |
| 20 | LRRK2 | 1.62444013 |
| 21 | TYK2 | 1.61010484 |
| 22 | TGFBR2 | 1.56203478 |
| 23 | PTK6 | 1.51574618 |
| 24 | TAOK3 | 1.48293388 |
| 25 | CLK1 | 1.47863486 |
| 26 | HIPK2 | 1.46576523 |
| 27 | ITK | 1.46209137 |
| 28 | CSF1R | 1.44079396 |
| 29 | IKBKE | 1.41094634 |
| 30 | TLK1 | 1.38816638 |
| 31 | KIT | 1.36504967 |
| 32 | FGFR4 | 1.36399833 |
| 33 | SIK2 | 1.33521654 |
| 34 | MAP2K2 | 1.32447282 |
| 35 | IRAK2 | 1.31836205 |
| 36 | BLK | 1.30969464 |
| 37 | SYK | 1.27010375 |
| 38 | MAP3K3 | 1.26928903 |
| 39 | RIPK1 | 1.24779417 |
| 40 | BCKDK | 1.21234088 |
| 41 | TBK1 | 1.18280330 |
| 42 | FLT3 | 1.17235660 |
| 43 | PASK | 1.14131963 |
| 44 | TGFBR1 | 1.13330866 |
| 45 | CDK12 | 1.10801532 |
| 46 | BRD4 | 1.08644878 |
| 47 | MARK2 | 1.06298163 |
| 48 | NME2 | 1.06184369 |
| 49 | EPHB1 | 1.05362983 |
| 50 | DMPK | 1.05296093 |
| 51 | VRK2 | 1.04406509 |
| 52 | MAP2K3 | 1.03261210 |
| 53 | PRKCH | 1.02253805 |
| 54 | JAK1 | 1.02172155 |
| 55 | RPS6KA4 | 1.00485988 |
| 56 | PIM2 | 1.00333577 |
| 57 | SGK3 | 0.98933209 |
| 58 | ALK | 0.98761104 |
| 59 | HCK | 0.95953234 |
| 60 | LCK | 0.92648823 |
| 61 | MAP3K1 | 0.91810022 |
| 62 | STK4 | 0.91612758 |
| 63 | SMG1 | 0.90816175 |
| 64 | PIM1 | 0.90815021 |
| 65 | SIK1 | 0.89990470 |
| 66 | EPHA3 | 0.89644954 |
| 67 | KDR | 0.88759919 |
| 68 | PRKD2 | 0.88667814 |
| 69 | SRPK1 | 0.88026598 |
| 70 | IRAK4 | 0.86851522 |
| 71 | NLK | 0.84464460 |
| 72 | FGR | 0.84283235 |
| 73 | FES | 0.83794129 |
| 74 | MAP3K7 | 0.82864913 |
| 75 | MARK3 | 0.82748964 |
| 76 | CDK4 | 0.80896055 |
| 77 | FGFR3 | 0.79829749 |
| 78 | DAPK1 | 0.78037857 |
| 79 | LMTK2 | 0.77642122 |
| 80 | JAK2 | 0.76761841 |
| 81 | TTN | 0.76408101 |
| 82 | CSK | 0.75522684 |
| 83 | TEC | 0.75342335 |
| 84 | TAOK1 | 0.72952307 |
| 85 | CHUK | 0.72825181 |
| 86 | RPS6KB2 | 0.71265916 |
| 87 | SCYL2 | 0.70370980 |
| 88 | CDC7 | 0.69336460 |
| 89 | TESK2 | 0.68498847 |
| 90 | MATK | 0.68362828 |
| 91 | IRAK1 | 0.68090606 |
| 92 | PRKD3 | 0.67498951 |
| 93 | TNK2 | 0.65796739 |
| 94 | MAP3K5 | 0.64021273 |
| 95 | ARAF | 0.63994049 |
| 96 | DYRK1B | 0.63085358 |
| 97 | NTRK2 | 0.62176650 |
| 98 | MAPK12 | 0.60300797 |
| 99 | IKBKB | 0.60155953 |
| 100 | RPS6KA6 | 0.58999277 |
| 101 | CAMK4 | 0.58866062 |
| 102 | YES1 | 0.57240398 |
| 103 | MAPKAPK2 | 0.57091618 |
| 104 | RPS6KA2 | 0.56962044 |
| 105 | IRAK3 | 0.56746210 |
| 106 | BMX | 0.56330998 |
| 107 | CDK9 | 0.55760773 |
| 108 | ILK | 0.55630673 |
| 109 | FYN | 0.54135650 |
| 110 | LYN | 0.54039179 |
| 111 | MAPK11 | 0.54022268 |
| 112 | RPS6KC1 | 0.52823298 |
| 113 | RPS6KL1 | 0.52823298 |
| 114 | MAP3K14 | 0.49817313 |
| 115 | CDC42BPA | 0.47601777 |
| 116 | PDK1 | 0.46828945 |
| 117 | MAP3K6 | 0.44870067 |
| 118 | PRKD1 | 0.44627878 |
| 119 | UHMK1 | 0.44532301 |
| 120 | MAP3K8 | 0.44366507 |
| 121 | DYRK3 | 0.44336306 |
| 122 | MAPK7 | 0.43561145 |
| 123 | RAF1 | 0.41362244 |
| 124 | ATR | 0.41332200 |
| 125 | SGK2 | 0.41085754 |
| 126 | MAP3K11 | 0.40719974 |
| 127 | PRKCQ | 0.40645759 |
| 128 | MAP2K6 | 0.40271934 |
| 129 | STK11 | 0.38590531 |
| 130 | MAPK3 | 0.38532460 |
| 131 | RPS6KA1 | 0.37700311 |
| 132 | PAK6 | 0.36884185 |
| 133 | RPS6KA5 | 0.36680681 |
| 134 | MAPK4 | 0.36293363 |
| 135 | PAK4 | 0.35640508 |
| 136 | KSR2 | 0.35313417 |
| 137 | CAMKK1 | 0.35291296 |
| 138 | MTOR | 0.35081639 |
| 139 | ICK | 0.34926208 |
| 140 | MAP3K13 | 0.34441336 |
| 141 | PAK1 | 0.34297126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.68375234 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.67819231 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.49701962 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.39463092 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.36226608 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.18849452 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.06296499 |
| 8 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.04003304 |
| 9 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.92271183 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 1.85362143 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.84639319 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80046632 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.75531830 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.73237276 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.71689930 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.71054565 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.67765386 |
| 18 | Mismatch repair_Homo sapiens_hsa03430 | 1.65863567 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.62303324 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.51886182 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.50213376 |
| 22 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.50077189 |
| 23 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.45112393 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43819957 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.42488720 |
| 26 | Spliceosome_Homo sapiens_hsa03040 | 1.41732390 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.39388246 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.38947988 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.35683563 |
| 30 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.28311774 |
| 31 | HTLV-I infection_Homo sapiens_hsa05166 | 1.27304561 |
| 32 | Sulfur relay system_Homo sapiens_hsa04122 | 1.27267839 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.26935726 |
| 34 | Colorectal cancer_Homo sapiens_hsa05210 | 1.26127824 |
| 35 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.24499059 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.23581026 |
| 37 | Ribosome_Homo sapiens_hsa03010 | 1.22541982 |
| 38 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.19904687 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19825313 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19766047 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19237972 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18585676 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.18142915 |
| 44 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.17125901 |
| 45 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.14741577 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.12562304 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.11655206 |
| 48 | Endometrial cancer_Homo sapiens_hsa05213 | 1.08500409 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07613487 |
| 50 | Lysine degradation_Homo sapiens_hsa00310 | 1.06176879 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05719473 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.05072769 |
| 53 | Apoptosis_Homo sapiens_hsa04210 | 1.05069768 |
| 54 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.04914681 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.04824809 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 1.04478681 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.04224157 |
| 58 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.03697652 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 1.02891088 |
| 60 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.01313937 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.01290775 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 1.00719550 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 1.00216776 |
| 64 | Influenza A_Homo sapiens_hsa05164 | 0.99462573 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98660627 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98548928 |
| 67 | Phagosome_Homo sapiens_hsa04145 | 0.98326127 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.97225083 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97158186 |
| 70 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.96505828 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.96495162 |
| 72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95381850 |
| 73 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.95122160 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94735268 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.93030891 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91421573 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.90823787 |
| 78 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.90363752 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89924253 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.87477737 |
| 81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.83290526 |
| 82 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.78565114 |
| 83 | Cell cycle_Homo sapiens_hsa04110 | 0.76377903 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.74780695 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.74233673 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72948586 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71782681 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71376071 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70969866 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70483153 |
| 91 | Alcoholism_Homo sapiens_hsa05034 | 0.69083847 |
| 92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67511522 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67364519 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66753781 |
| 95 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.66412837 |
| 96 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66242103 |
| 97 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.65594765 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.65207354 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63253938 |
| 100 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.62592941 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.62362220 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.62178102 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.62060599 |
| 104 | Tuberculosis_Homo sapiens_hsa05152 | 0.61340297 |
| 105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60856843 |
| 106 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.59652641 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59332790 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59297513 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57943329 |
| 110 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57722765 |
| 111 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56746590 |
| 112 | ABC transporters_Homo sapiens_hsa02010 | 0.55299529 |
| 113 | Prostate cancer_Homo sapiens_hsa05215 | 0.54567954 |
| 114 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.53798910 |
| 115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.53190770 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53119543 |
| 117 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.52482971 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52291912 |
| 119 | Pathways in cancer_Homo sapiens_hsa05200 | 0.52150166 |
| 120 | Homologous recombination_Homo sapiens_hsa03440 | 0.50766935 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50413718 |
| 122 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50105719 |
| 123 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.49357945 |
| 124 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.48000397 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47213734 |
| 126 | RNA degradation_Homo sapiens_hsa03018 | 0.46982441 |
| 127 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.46834772 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46330789 |
| 129 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45231697 |
| 130 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42545195 |
| 131 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42271853 |
| 132 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.40178390 |
| 133 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.39187409 |
| 134 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36941721 |
| 135 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36418408 |
| 136 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.32710789 |

